Sorafenib Monotherapy vs. TACE-sorafenib Sequential Therapy for HCC With Metastasis

Press/Media: Press / Media

Period2018 Oct 2

Media coverage

1

Media coverage

  • TitleSorafenib Monotherapy vs. TACE-sorafenib Sequential Therapy for HCC With Metastasis
    Media name/outletClinical Trials.gov
    CountryUnited States
    Date18/10/2
    PersonsJunyong Park